Back to search

France· FR:68257528

ABACAVIR/LAMIVUDINE ACCORD 600 mg/300 mg, comprimé pelliculé

A medicinal product, registered in France by ACCORD HEALTHCARE FRANCE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedABACAVIR/LAMIVUDINE ACCORD 600 mg/300…ATC—REGISTER NO.FR:68257528PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
ACCORD HEALTHCARE FRANCE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930083420
    plaquette(s) PVC (ACLAR RX) polytrifluorochloroéthylène aluminium de 30 comprimé(s)
    EUR 134.42

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

ABACAVIR/LAMIVUDINE in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ABACAVIR/LAMIVUDINE products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Abacavir/Lamivudin Ratiopharm, Abacavir/Lamivudin Sandoz
  • Belgium · Abacavir/Lamivudine Viatris
  • Bulgaria · Abacavir/Lamivudine Viatris, Абакавир/Ламивудин Майлан
  • Cyprus · Kivala
  • Germany · Abacavir/Lamivudin Al, Abacavir/Lamivudin Aurobindo
  • Denmark · Abacavir/Lamivudin Medical Valley, Abacavir/Lamivudin Mylan
  • Estonia · Abacavir/Lamivudine Auxilia, Abacavir/Lamivudine Mylan
  • Spain · Abacavir/Lamivudina Aurovitas, Abacavir/Lamivudina Dr. Reddys
  • Finland · Abacavir/Lamivudin Mylan, Abacavir/Lamivudin Viatris
  • United Kingdom (Northern Ireland) · Abacavir/Lamivudin Sandoz, Abacavir/Lamivudine Accord
  • Greece · Abacavir+lamivudine Mylan Pharma, Varistren
  • Hungary · Abacavir/Lamivudine Teva
  • Ireland · Abacavir/Lamivudine Mylan, Abacavir/Lamivudine Viatris
  • Iceland · Kivexa
  • Italy · Abacavir E Lamivudina Aurobindo, Abacavir E Lamivudina Sun
  • Liechtenstein · Kivexa
  • Lithuania · Abacavir / Lamivudine Auxilia, Abacavir/Lamivudine Accord
  • Luxembourg · Abacavir/Lamivudine Viatris
  • Latvia · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Mylan
  • Netherlands · Abacavir Sulfate / Lamivudine Aurobindo, Abacavir/Lamivudin Teva
  • Norway · Abacavir/Lamivudin Mylan, Abacavir/Lamivudine Viatris
  • Poland · Abacavir + Lamivudine Sandoz
  • Portugal · Abacavir + Lamivudina Aurovitas, Abacavir + Lamivudina Farmoz
  • Romania · Abacavir/Lamivudină, Abacavir/Lamivudină Mylan
  • Sweden · Abacavir/Lamivudine Accord, Abacavir/Lamivudine Glenmark

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/810a5415-e76a-47ba-832d-79b8ca13751a
GET /v1/drugs/810a5415-e76a-47ba-832d-79b8ca13751a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "68257528",
  "date_amm": "2017-03-16",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "statut_amm": "Autorisation archivée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about ABACAVIR/LAMIVUDINE.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.